0/3-hour high-sensitivity cardiac troponin algorithm: High-sensitivity cardiac troponin measurements obtained at presentation and 3 hours after the initial sample as part of the conventional diagnostic strategy for suspected acute coronary syndrome.
0/1-hour high-sensitivity cardiac troponin algorithm: High-sensitivity cardiac troponin measurements obtained at presentation and 1 hour after the initial sample as part of the accelerated diagnostic strategy for suspected acute coronary syndrome.
People with chest pain are often tested for a heart attack using a blood test called high-sensitivity cardiac troponin (hs-cTn). Traditionally, this blood test is repeated 3 hours after the first sample. Newer guidelines recommend repeating the test after 1 hour instead, which may allow patients to receive a diagnosis and leave the hospital sooner.
The purpose of the DanRUSH trial is to compare these two strategies: repeating the blood test after 1 hour versus after 3 hours in adults with suspected acute coronary syndrome. The study will evaluate whether the 1-hour strategy is as safe as the 3-hour strategy while reducing the length of hospital stay.
DanRUSH is a nationwide, pragmatic, cluster-randomized trial conducted in emergency- and cardiology departments across Denmark. The results will help determine the best timing for blood testing in patients with suspected heart attack and improve future care for these patients.
| Facility | City | Region | Status |
|---|---|---|---|
| Aalborg University Hospital | Aalborg | Denmark | |
| Bispebjerg & Frederiksberg Hospital | Bispebjerg | Denmark | |
| Esbjerg og Grindsted Sygehus | Esbjerg | Denmark | |
| Gødstrup Regional Hospital | Gødstrup | Denmark | |
| Herlev & Gentofte Hospital | Herlev | Denmark | |
| Nordsjællands Hospital | Hillerød | Denmark | |
| Amager & Hvidovre Hospital | Hvidovre | Denmark | |
| Nykøbing Falster County Hospital | Nykøbing Falster | Denmark | |
| Odense University Hospital | Odense | Denmark | |
| Svendborg Hospital | Svendborg | Denmark | |
| Central Jutland Regional Hospital (Viborg Hospital & Silkeborg Hospital) | Viborg | Denmark |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07727135 on ClinicalTrials.gov ↗ ← All trials in Denmark